Literature DB >> 3597401

Purification and sequencing of a trypsin-sensitive cholecystokinin-releasing peptide from rat pancreatic juice. Its homology with pancreatic secretory trypsin inhibitor.

K Iwai, S Fukuoka, T Fushiki, M Tsujikawa, M Hirose, S Tsunasawa, F Sakiyama.   

Abstract

The trypsin-sensitive cholecystokinin-releasing peptide is a peptide purified from rat pancreatic juice on the basis of its stimulatory activity toward pancreatic enzyme secretion. We postulate that the peptide acts as a mediator of pancreatic enzyme secretion in response to dietary protein intake and that it (designated as "monitor peptide" from its role in the intestine) could be responsible for the feedback regulation of pancreatic enzyme secretion. About 20 nmol of the highly purified peptide were obtained from 800 ml of rat pancreatic juice by reverse-phase high performance liquid chromatography. It was then sequenced. The peptide comprises 61 amino acid residues (Table I). It has a sequence that closely resembles that of a highly conserved region in pancreatic secretory trypsin inhibitors (PSTIs, Kazal type inhibitor): -Ile-Tyr-Asx-Pro-Val-Cys-Gly-Thr-Asx-Gly-. However, the peptide is less related to other mammalian PSTIs than they are to each other. The additional 5 residues at the NH2 terminus make the peptide larger than the common 56-residue PSTIs. The trypsin-sensitive cholecystokinin-releasing peptide is to be classified as a Kazal-type inhibitor and may be one of the rat PSTIs or a related peptide. The present results and increasing evidence from other laboratories and ours suggest that Kazal-type inhibitors play previously unrecognized multiple physiological roles.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3597401

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Cholecystokinin cells purified by fluorescence-activated cell sorting respond to monitor peptide with an increase in intracellular calcium.

Authors:  R A Liddle; M A Misukonis; L Pacy; A E Balber
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

2.  Pancreatic secretory trypsin inhibitor in gastrointestinal mucosa and gastric juice.

Authors:  T C Freeman; R J Playford; C Quinn; K Beardshall; L Poulter; J Young; J Calam
Journal:  Gut       Date:  1990-11       Impact factor: 23.059

3.  Diazepam-binding inhibitor mediates feedback regulation of pancreatic secretion and postprandial release of cholecystokinin.

Authors:  Y Li; Y Hao; C Owyang
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

4.  Diazepam binding inhibitor is a potent cholecystokinin-releasing peptide in the intestine.

Authors:  K H Herzig; I Schön; K Tatemoto; Y Ohe; Y Li; U R Fölsch; C Owyang
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

5.  Cefaclor, a cephalosporin antibiotic, delays gastric emptying rate by a CCK-A receptor-mediated mechanism in the rat.

Authors:  A Bozkurt; M Deniz; B C Yegen
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

6.  Overexpression of pancreatic secretory trypsin inhibitor in pancreatic cancer. Evaluation of its biological function as a growth factor.

Authors:  Y Ohmachi; A Murata; N Matsuura; T Yasuda; K Uda; T Mori
Journal:  Int J Pancreatol       Date:  1994-02

7.  Endogenous elevation of plasma cholecystokinin does not prevent gallstones.

Authors:  Rafiq A Shahid; David Q-H Wang; Brian E Fee; Shannon J McCall; Joelle M-J Romac; Steven R Vigna; Rodger A Liddle
Journal:  Eur J Clin Invest       Date:  2015-03       Impact factor: 4.686

8.  Regulation of intestinal concentration of cholecystokinin by bile and/or pancreatic juice.

Authors:  K Miyasaka; A Funakoshi; M Matsumoto; K Kitani
Journal:  Dig Dis Sci       Date:  1993-04       Impact factor: 3.199

9.  A specific binding of the cholecystokinin-releasing peptide (monitor peptide) to isolated rat small-intestinal cells.

Authors:  R Yamanishi; J Kotera; T Fushiki; T Soneda; T Saitoh; T Oomori; T Satoh; E Sugimoto
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

10.  Purification and characterization of a luminal cholecystokinin-releasing factor from rat intestinal secretion.

Authors:  A W Spannagel; G M Green; D Guan; R A Liddle; K Faull; J R Reeve
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.